Nada Babović

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić et al. · Clinical & Experimental Metastasis · 2007 · 91 citations

Life Sciences, Immunology, Oncology +14

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen et al. · JAMA Oncology · 2022 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells

Gordana Konjević, Katarina Mirjačić Martinović, Vladimir Jurišić et al. · Biomarkers · 2009 · 73 citations

Life Sciences, Immunology, Oncology +17

Phase II trial of pirfenidone in adults with neurofibromatosis type 1

Dusica Babovic‐Vuksanovic, Karla V. Ballman, Virginia V. Michels et al. · Neurology · 2006 · 71 citations

Medicine, Neurology, Oncology +14

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

Jean‐Yves Blay, Zsuzsanna Pápai, Anthony W. Tolcher et al. · The Lancet Oncology · 2015 · 66 citations

Medicine, Oncology, Pharmacology +12